Subbarao Jayanthi

Biopharma companies can foster patient-centered innovation by focusing on unmet needs along each stage of the patient journey while collaborating with key stakeholders directly or indirectly responsible for disease management.

Biopharma must step up amidst growing oncology market.

Focusing on prevention, diagnosis, treatment, and care monitoring during the patient journey in oncology to create value for stakeholders.

Examining the current biosimilar market.

A check on the evolving challenges and potential solutions in steering future market adoption of curative-intended treatments.

While gene therapies continue to revolutionize healthcare, uncertainty from commercialization issues still looms large.